Heather Bresch

Look, I think if you've got a niche portfolio or just operating in one country, like the United States, your ability to absorb the volatility is much less.

Throughout our history we have been tireless advocates for expanding access to high-quality, affordable medicine. This is especially true in the area of HIV/AIDS.

As a mother of four children, I want to know the drugs I'm giving them are safe. And as an American businesswoman, I want to keep jobs here, and that means making sure foreign drug plants have to meet the same standards as domestic ones.

We are driven by the belief that every person in this world matters and access to better health is a right, not a privilege.

Treating everyone with dignity and respect is of utmost importance to me and are values we instill and take very seriously at Mylan.

Patients deserve increased price transparency and affordable care, particularly as the system shifts significant costs to them.

The value that the generic drug industry brings to the U.S. healthcare system is indisputable.

The pharma pricing system was not built on the idea of consumer engagement. It was built... on market efficiencies. It was not built on the premise of consumerism.

People can put their capital to work where they like.

There is simply no substitute for hard work when it comes to achieving success.